Lv5
1090 积分 2021-12-10 加入
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma
2天前
已完结
Belzutifan (MK-6482): Biology and Clinical Development in Solid Tumors
3天前
已完结
Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors
2个月前
已完结
T-cell-engaging bispecific antibodies in cancer
2个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
2个月前
已完结
Antibodies to watch in 2025
3个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
3个月前
已完结
Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With ROS1-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study
3个月前
已完结
Non-small-cell lung cancer
3个月前
已完结
LBA54 Amivantamab plus chemotherapy vs chemotherapy in EGFR-mutated, advanced non-small cell lung cancer after disease progression on osimertinib: Second interim overall survival from MARIPOSA-2
3个月前
已关闭
皖公网安备34019202002308
